Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A paper by Oxford BRC-supported researchers says that linking research funding to Athena SWAN gender equality action plans has been associated with a rise in the number of women in mid-level leadership positions and the proportion of funding going to women.

Female scientist in the lab © Medical Sciences Division and John Cairns

The paper, published in the BMJ, said that more funders should trial funding incentives as they have been shown to work. The research team was led by Pavel Ovseiko, Senior Research Fellow in the Radcliffe Department of Medicine.

To accelerate women’s advancement and leadership, the National Institute for Health Research (NIHR) in 2011 linked its research funding to the implementation by universities of gender equality action plans through the Athena SWAN (Scientific Women’s Academic Network) charter.

In the 2016 round of the competition, the NIHR said it would not shortlist any research centre where the academic partners had not achieved at least the Athena SWAN silver award.

After the introduction of the Athena SWAN incentives, the proportion of female theme leads in BRCs increased from 8%in both 2006 and 2011 to 24% in 2016. The proportion of women in senior director positions also increased, albeit more modestly, from 11% in 2006 and 10% in 2011 to 15% in 2016.

The full story is available on the NIHR Oxford Biomedical Research Centre website

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Professor Hugh Watkins wins £30 million research award to cure killer heart diseases

The British Heart Foundation award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine.

Six RDM research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Ewa Gogola receives Wellcome Early Career Award

Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project ‘DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?’